From enzymes and lipid nanoparticles to large-scale process design, four global innovators redefine RNA-based medicine development and delivery.

During the upscaling process, Polyrizon and its manufacturing partner successfully transitioned from small-batch laboratory production to a larger-scale, controlled manufacturing run designed to ...

Why SaaS Founders Should Care About HDD Building a startup means constantly navigating trade-offs: limited capital, ...

This guide distils that experience into a clear, practical path. While the stages appear sequential, product development ...